Ikarian Capital, LLC Dice Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Dice Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 43,600 shares of DICE stock, worth $0. This represents 0.37% of its overall portfolio holdings.
Number of Shares
43,600Holding current value
$0% of portfolio
0.37%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding DICE
# of Institutions
3Shares Held
17.7KCall Options Held
13KPut Options Held
0About DICE Therapeutics, Inc.
- Ticker DICE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,430,000
- Description
- DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...